newsfilter
← Latest News
GlobeNewswire·

BioCardia Reports Third Quarter 2025 Business Highlights and Financial Results

SUNNYVALE, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ:BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported